Merck Seeking to Help Covid Vaccine Manufacturers: EVP

The transcript discusses Merck's efforts to aid India during the pandemic, including financial donations and licensing agreements for drug production. It highlights the complexities of vaccine manufacturing and the challenges of waiving intellectual property rights. The discussion also covers global vaccine distribution barriers, the impact of virus variants, and the need for vaccine boosters. Additionally, it addresses the neglect of regular health services and immunizations during the pandemic, raising concerns about potential outbreaks of diseases like measles.

What strategies are suggested to improve vaccine access in developing countries?

What is the significance of the partnerships mentioned in the text regarding vaccine distribution?

What role do raw materials play in the vaccine manufacturing process as discussed in the text?